33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-679.04%
Negative net income growth while CFLT stands at 8.76%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-25.40%
Negative yoy D&A while CFLT is 19.76%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-88.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
18305.81%
SBC growth well above CFLT's 0.84%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-72.37%
Negative yoy working capital usage while CFLT is 45.75%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-204.89%
Both yoy AR lines negative, with CFLT at -689.80%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-2473.68%
Negative yoy inventory while CFLT is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
204.05%
Lower AP growth vs. CFLT's 810.36%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-41.32%
Negative yoy usage while CFLT is 217.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
106.95%
Some yoy increase while CFLT is negative at -22.62%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-17.07%
Negative yoy CFO while CFLT is 35.15%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-155.16%
Negative yoy CapEx while CFLT is 1.17%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-151.06%
Both yoy lines negative, with CFLT at -289.59%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-33.97%
We cut debt repayment yoy while CFLT is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth at 75-90% of CFLT's 121.84%. Bill Ackman would call for more share repurchases if undervaluation is evident, to match competitor’s approach.